Terme Catez, d.d. (LJSE:TCRG)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30	31	30	16	17	14
Market Cap Growth	3.23%	3.23%	85.63%	-4.57%	19.05%	-26.50%
Enterprise Value	42	57	60	50	52	59
Last Close Price	62.00	64.00	61.31	33.03	34.61	29.07
PE Ratio	11.94	12.33	14.59	16.60	2.18	-
PS Ratio	0.78	0.80	0.90	0.52	0.68	0.77
PB Ratio	0.31	0.32	0.32	0.17	0.18	0.16
P/TBV Ratio	0.31	0.32	0.32	0.17	0.18	0.16
P/FCF Ratio	-	-	7.64	8.46	10.53	-
P/OCF Ratio	31.59	32.61	4.44	3.00	1.97	10.18
EV/Sales Ratio	1.09	1.45	1.77	1.57	2.06	3.13
EV/EBITDA Ratio	4.62	6.19	10.59	8.08	7.88	-
EV/EBIT Ratio	8.23	11.01	35.06	22.89	21.60	-
EV/FCF Ratio	-11.09	-	15.00	25.79	32.07	-
Debt / Equity Ratio	0.15	0.15	0.29	0.33	0.35	0.53
Debt / EBITDA Ratio	1.62	1.62	5.01	5.30	5.12	-
Debt / FCF Ratio	-	-	7.09	16.93	20.91	-
Asset Turnover	0.27	0.27	0.23	0.21	0.16	0.12
Inventory Turnover	47.35	47.35	52.04	55.50	47.04	34.03
Quick Ratio	0.26	0.26	0.41	0.30	0.15	0.11
Current Ratio	0.55	0.55	0.45	0.32	0.17	0.38
Return on Equity (ROE)	2.61%	2.61%	2.14%	1.00%	8.07%	-4.15%
Return on Assets (ROA)	2.21%	2.21%	0.71%	0.90%	0.96%	-0.25%
Return on Capital (ROIC)	2.71%	2.71%	0.83%	1.03%	1.12%	-0.30%
Return on Capital Employed (ROCE)	4.20%	4.20%	1.40%	1.70%	2.00%	-
Earnings Yield	8.37%	8.11%	6.85%	6.02%	45.90%	-21.48%
FCF Yield	-12.58%	-12.18%	13.09%	11.82%	9.50%	-16.77%
Dividend Yield	0.81%	-	0.82%	-	-	-
Total Shareholder Return	0.81%	-	0.82%	-	-	-

Updated Sep 29, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.